{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:21:13Z","timestamp":1792801273314,"version":"4.5.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.jns.2014.10.037","type":"journal-article","created":{"date-parts":[[2014,10,31]],"date-time":"2014-10-31T13:10:46Z","timestamp":1414761046000},"page":"380-382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Myopathy during treatment with the antianginal drug ranolazine"],"prefix":"10.1016","volume":"347","author":[{"given":"Charles D.","family":"Kassardjian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgirene","family":"Vladutiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee-Jun","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Milone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2014.10.037_bb0005","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jacc.2003.11.045","article-title":"Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina","volume":"43","author":"Chaitman","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jns.2014.10.037_bb0010","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0014-2999(01)00920-7","article-title":"Ranolazine, a partial fatty acid oxidation inhibitor, reduces myocardial infarct size and cardiac troponin T release in the rat","volume":"418","author":"Zacharowski","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jns.2014.10.037_bb0015","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1001\/archneurol.2012.206","article-title":"Heterogeneity of coenzyme Q10 deficiency: patient study and literature review","volume":"69","author":"Emmanuele","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2014.10.037_bb0020","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ajhg.2007.12.024","article-title":"ADCK3, an ancestral kinase, is mutated in a form of recessive ataxia associated with coenzyme Q10 deficiency","volume":"82","author":"Lagier-Tourenne","year":"2008","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jns.2014.10.037_bb0025","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s10545-010-9080-z","article-title":"Clinical aspects of short-chain acyl-CoA dehydrogenase deficiency","volume":"33","author":"van Maldegem","year":"2010","journal-title":"J Inherit Metab Dis"},{"issue":"20","key":"10.1016\/j.jns.2014.10.037_bb0030","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1161\/CIRCULATIONAHA.105.597500","article-title":"Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions","volume":"113","author":"Chaitman","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jns.2014.10.037_bb0035","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.2146\/ajhp090299","article-title":"Rhabdomyolysis in a patient receiving ranolazine and simvastatin","volume":"67","author":"Hylton","year":"2010","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jns.2014.10.037_bb0040","first-page":"264","article-title":"Multiple drug interactions in a renal transplant patient leading to simvastatin-induced rhabdomyolysis: a case report","volume":"10","author":"Rifkin","year":"2008","journal-title":"Medscape J Med"},{"key":"10.1016\/j.jns.2014.10.037_bb0045","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/CND.0b013e31828525a5","article-title":"Ranolazine-induced myopathy in a patient on chronic statin therapy","volume":"14","author":"Correa","year":"2013","journal-title":"J Clin Neuromuscul Dis"},{"key":"10.1016\/j.jns.2014.10.037_bb0050","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/mus.20567","article-title":"Genetic risk factors associated with lipid-lowering drug-induced myopathies","volume":"34","author":"Vladutiu","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2014.10.037_bb0055","first-page":"1634","article-title":"Toxic myopathies","volume":"19","author":"Mammen","year":"2013","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.jns.2014.10.037_bb0060","doi-asserted-by":"crossref","first-page":"581","DOI":"10.7326\/0003-4819-137-7-200210010-00009","article-title":"Statin-associated myopathy with normal creatine kinase levels","volume":"137","author":"Phillips","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jns.2014.10.037_bb0065","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1001\/archneur.62.11.1709","article-title":"Muscle coenzyme Q10 level in statin-related myopathy","volume":"62","author":"Lamperti","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2014.10.037_bb0070","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jacc.2012.09.036","article-title":"Simvastatin effects on skeletal muscle: relation to decreased mitochondrial function and glucose intolerance","volume":"61","author":"Larsen","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jns.2014.10.037_bb0075","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1177\/0091270004273992","article-title":"Studies to investigate the pharmacokinetic interactions between ranolazine and ketoconazole, diltiazem, or simvastatin during combined administration in healthy subjects","volume":"45","author":"Jerling","year":"2005","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jns.2014.10.037_bb0080","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.jacc.2009.01.037","article-title":"Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 Trial","volume":"53","author":"Wilson","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jns.2014.10.037_bb0085","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1136\/bmj.1.6072.1319","article-title":"Proximal myopathy after perhexiline maleate treatment","volume":"1","author":"Tomlinson","year":"1977","journal-title":"Br Med J"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X14007059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X14007059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T03:22:02Z","timestamp":1538104922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X14007059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":17,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0022510X14007059"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2014.10.037","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myopathy during treatment with the antianginal drug ranolazine","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2014.10.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}